Content
02/05/2025
Alameda, CA USA
Miist Therapeutics
completed $7 million Seed Round funding. Investors include
1517 Fund, California Innovation Fund, Entrepreneur First, Freeflow Ventures, Refactor Capital.
About
Miist Therapeutics applies a physics-based approach to develop inhaled therapies that are faster acting and more effective than today's standard of care. The company's core technology is an inhaler that uses ultrasonic vibration to generate and deliver 2-micron aqueous drug particles to the peripheral lung, where they are instantly absorbed into the bloodstream. Using this novel approach, Miist is developing new inhaled therapies that will deliver instant relief for some of our most common and debilitating conditions.
Startup
Sector:
Biotech
Life Science
Download StockFan App
Ad
Stock market data, news and community, all integrated.
Features include real time stock quotes, interactive charts, technical signals, institutional & insider ownerships, stock screener, ETF rankings, SEC filings, press releases, videos, earnings calendar, social media posts, group chats.
